{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T18:24:32Z","timestamp":1789928672596,"version":"4.0.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T00:00:00Z","timestamp":1441152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1038\/pr.2015.169","type":"journal-article","created":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T16:00:52Z","timestamp":1441209652000},"page":"717-722","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Safety and clinical activity of elosulfase alfa in pediatric patients with Morquio A syndrome (mucopolysaccharidosis IVA) less than 5 y"],"prefix":"10.1038","volume":"78","author":[{"given":"Simon A.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bialer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4505-1306","authenticated-orcid":false,"given":"Rossella","family":"Parini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Shaywitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Harmatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,2]]},"reference":[{"key":"BFpr2015169_CR1","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/humu.20257","volume":"26","author":"S Tomatsu","year":"2005","unstructured":"Tomatsu S, Monta\u00f1o AM, Nishioka T, et al. Mutation and polymorphism spectrum of the GALNS gene in mucopolysaccharidosis IVA (Morquio A). Hum Mutat 2005;26:500\u201312.","journal-title":"Hum Mutat"},{"key":"BFpr2015169_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ymgme.2014.03.004","volume":"112","author":"A Morrone","year":"2014","unstructured":"Morrone A, Tylee KL, Al-Sayed M, et al. Molecular testing of 163 patients with Morquio A (Mucopolysaccharidosis IVA) identifies 39 novel GALNS mutations. Mol Genet Metab 2014;112:160\u201370.","journal-title":"Mol Genet Metab"},{"key":"BFpr2015169_CR3","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2174\/138920111795542615","volume":"12","author":"S Tomatsu","year":"2011","unstructured":"Tomatsu S, Monta\u00f1o AM, Oikawa H, et al. Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment. Curr Pharm Biotechnol 2011;12:931\u201345.","journal-title":"Curr Pharm Biotechnol"},{"key":"BFpr2015169_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ymgme.2013.01.021","volume":"109","author":"P Harmatz","year":"2013","unstructured":"Harmatz P, Mengel KE, Giugliani R, et al. The Morquio A Clinical Assessment Program: baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects. Mol Genet Metab 2013;109:54\u201361.","journal-title":"Mol Genet Metab"},{"key":"BFpr2015169_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10545-012-9459-0","volume":"36","author":"CJ Hendriksz","year":"2013","unstructured":"Hendriksz CJ, Al-Jawad M, Berger KI, et al. Clinical overview and treatment options for non-skeletal manifestations of mucopolysaccharidosis type IVA. J Inherit Metab Dis 2013;36:309\u201322.","journal-title":"J Inherit Metab Dis"},{"key":"BFpr2015169_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10545-007-0529-7","volume":"30","author":"AM Monta\u00f1o","year":"2007","unstructured":"Monta\u00f1o AM, Tomatsu S, Gottesman GS, Smith M, Orii T. International Morquio A Registry: clinical manifestation and natural course of Morquio A disease. J Inherit Metab Dis 2007;30:165\u201374.","journal-title":"J Inherit Metab Dis"},{"key":"BFpr2015169_CR7","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/ajmg.a.32281","volume":"146A","author":"AM Monta\u00f1o","year":"2008","unstructured":"Monta\u00f1o AM, Tomatsu S, Brusius A, Smith M, Orii T. Growth charts for patients affected with Morquio A disease. Am J Med Genet A 2008;146A:1286\u201395.","journal-title":"Am J Med Genet A"},{"key":"BFpr2015169_CR8","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s40265-014-0210-z","volume":"74","author":"M Sanford","year":"2014","unstructured":"Sanford M, Lo JH. Elosulfase alfa: first global approval. Drugs 2014;74:713\u20138.","journal-title":"Drugs"},{"key":"BFpr2015169_CR9","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s10545-014-9715-6","volume":"37","author":"CJ Hendriksz","year":"2014","unstructured":"Hendriksz CJ, Burton B, Fleming TR, et al.; STRIVE Investigators. Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study. J Inherit Metab Dis 2014;37:979\u201390.","journal-title":"J Inherit Metab Dis"},{"key":"BFpr2015169_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ymgme.2014.08.012","volume":"114","author":"CJ Hendriksz","year":"2015","unstructured":"Hendriksz CJ, Giugliani R, Harmatz P, et al.; STRIVE Investigators. Multi-domain impact of elosufase alfa in Morquio A syndrome in the pivotal phase III trial. Mol Genet Metab 2015;114:178\u201385.","journal-title":"Mol Genet Metab"},{"key":"BFpr2015169_CR11","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/j.ymgme.2011.11.076","volume":"105","author":"C Hendriksz","year":"2012","unstructured":"Hendriksz C, Vellodi A, Jones S, et al. Long term outcomes of a phase 1\/2, multicenter, open-label, dose-escalation study to evaluate the safety, tolerability, and efficacy of BMN 110 in patients with mucopolysaccharidosis IVA (Morquio A syndrome). Mol Genet Metab 2012;105:S35.","journal-title":"Mol Genet Metab"},{"key":"BFpr2015169_CR12","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.4155\/bio.11.172","volume":"3","author":"LA Martell","year":"2011","unstructured":"Martell LA, Cunico RL, Ohh J, Fulkerson W, Furneaux R, Foehr ED. Validation of an LC-MS\/MS assay for detecting relevant disaccharides from keratan sulfate as a biomarker for Morquio A syndrome. Bioanalysis 2011;3:1855\u201366.","journal-title":"Bioanalysis"},{"key":"BFpr2015169_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ymgme.2013.06.008","volume":"110","author":"VC D\u0169ng","year":"2013","unstructured":"D\u0169ng VC, Tomatsu S, Monta\u00f1o AM, et al. Mucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levels. Mol Genet Metab 2013;110:129\u201338.","journal-title":"Mol Genet Metab"},{"key":"BFpr2015169_CR14","first-page":"1","volume":"18","author":"A Quartel","year":"2015","unstructured":"Quartel A, Hendriksz CJ, Parini R, Graham S, Lin P, Harmatz P. Growth Charts for Individuals with Mucopolysaccharidosis VI (Maroteaux-Lamy Syndrome). JIMD Rep 2015;18:1\u201311.","journal-title":"JIMD Rep"},{"key":"BFpr2015169_CR15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10545-013-9658-3","volume":"37","author":"J de Ruijter","year":"2014","unstructured":"de Ruijter J, Broere L, Mulder MF, et al. Growth in patients with mucopolysaccharidosis type III (Sanfilippo disease). J Inherit Metab Dis 2014;37:447\u201354.","journal-title":"J Inherit Metab Dis"},{"key":"BFpr2015169_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/adc.51.3.170","volume":"51","author":"JM Tanner","year":"1976","unstructured":"Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976;51:170\u20139.","journal-title":"Arch Dis Child"},{"key":"BFpr2015169_CR17","unstructured":"Kuczmarski RJ, Ogden CL, Guo SS et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11 2002;1\u2013190."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr2015169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2015169","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/pr.2015.169","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/pr2015169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T21:53:35Z","timestamp":1718056415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr2015169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,2]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["BFpr2015169"],"URL":"https:\/\/doi.org\/10.1038\/pr.2015.169","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,2]]},"assertion":[{"value":"23 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}